NCT07760337

Brief Summary

Orthodontic treatment often causes pain during the initial alignment stage which can lead to discomfort, reduced compliance, and slower treatment progress. Potential Solution: Transcutaneous Electrical Nerve Stimulation (TENS) is a non-invasive, non-pharmacological approach that uses mild electrical currents to stimulate nerves and potentially reduce pain. This study uses a split-mouth design, with each patient acting as their own control. One side of their mouth receives the TENS therapy, while the other receives a placebo treatment (minimum current below the therapeutic level). This allows for a direct comparison of TENS effectiveness without the influence of individual pain variations. Research Goal: The study aims to determine whether TENS can effectively manage pain during initial orthodontic treatment. This would offer a safe and natural alternative to pain medications, potentially improving patient comfort and treatment outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable pain

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 20, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 2, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 2, 2024

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

August 7, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 12, 2026

Completed
Last Updated

August 12, 2026

Status Verified

August 1, 2026

Enrollment Period

7 months

First QC Date

August 7, 2026

Last Update Submit

August 7, 2026

Conditions

Keywords

Transcutaneous electrical nerve stimulationPainorthodontic wire

Outcome Measures

Primary Outcomes (1)

  • Pain will be measured after intervention at visual analogue scale

    pateint after giving TENS treatment will be asked to measure their pain score for right and left side on visual analogue scale

    pain will be marked on visual analogue scale at 0 hour , 6 hours, 24 hours, 48 hours

Study Arms (2)

TENS group

EXPERIMENTAL

Participants in this arm will receive two 5-minute sessions of TENS therapy with a 2-minute break in between. Self-adhesive electrode pads will be placed on the designated cheek as determined by randomization. The TENS device will be set at intensity that is comfortable for the participant. The device will deliver electrical pulses through the electrodes to stimulate sensory nerves and potentially reduce pain. Participants will receive this TENS therapy application immediately after the initial placement of the alignment archwire Both groups will be instructed to mark their pain levels on a visual analog scale (VAS) at 0, 6, 24, and 48 hours after the initial archwire placement.

Device: TENS

Placebo/Control group

SHAM COMPARATOR

Participants in this arm will receive a similar treatment that mimics the TENS application but with minimal current to maintain participant blinding. Similar to the TENS group, self-adhesive electrode pads will be placed on the designated cheek. The placebo device will be set at a very low intensity that only feels like a slight tingling sensation. This sham treatment serves as a control, allowing comparison of any pain reduction to the effects of real TENS therapy.Participants will receive this placebo treatment application on the same schedule as the TENS group - immediately after archwire placement

Device: TENS

Interventions

TENSDEVICE

Trancutaneous electrical nerve stimulation device with self-adhesive pads will be placed on patients cheeks. Experimental side will recveive active TENS treatment and other side will receive treatment with intensity of TENS set at low intensity (subtherapeutic)

Placebo/Control groupTENS group

Eligibility Criteria

Age18 Years - 57 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Foundation University Islamabad

Islamabad, Federal, 44000, Pakistan

Location

MeSH Terms

Conditions

Pain

Interventions

Transcutaneous Electric Nerve Stimulation

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
split-mouth study design interventional or placebo control side will be selected randomly through sealed envelope by an independent researcher not involved in the study .
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: Model: Parallel-Arm Design Model Description: This is a single-blind, randomized parallel-arm study with two arms. Participants will be randomly assigned to either receive TENS therapy or a placebo treatment. They will remain in their assigned group throughout the study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

August 7, 2026

First Posted

August 12, 2026

Study Start

March 20, 2024

Primary Completion

October 2, 2024

Study Completion

December 2, 2024

Last Updated

August 12, 2026

Record last verified: 2026-08

Locations